71298 Federal Register / Vol. 65, No. 231 / Thursday, November 30, 2000 / Notices

then include 8 bldgs. consisting of

609,927 sq. ft. (a 237% increase) on 225

acres.

The application also requests to

expand the scope of authority for

manufacturing activity conducted under

FTZ procedures at Subzone 93C to

include additional general categories of

inputs that have recently been approved

by the Board for other pharmaceutical

plants. They include chemically pure

sugars, empty capsules for

pharmaceutical use, protein

concentrates, natural magnesium

phosphates and carbonates, gypsum,

anhydrite and plasters, petroleum jelly,

paraffin and waxes, sulfuric acid, other

inorganic acids or compounds of

nonmetals, ammonia, zinc oxide,

titanium oxides, fluorides, chlorates,

sulfates, salts of oxometallic acids,

radioactive chemical elements,

compounds of rare earth metals, acyclic

hydrocarbons, derivatives of phenols or

peroxides, acetals and hemiacetals,

phosphoric esters and their salts, diazocompounds, glands for therapeutic uses,

wadding, gauze and bandages,

pharmaceutical glaze, hair preparations,

lubricating preparations, albumins,

prepared glues and adhesives, catalytic

preparations, diagnostic or laboratory

reagents, prepared binders, acrylic

polymers, self-adhesive plates and

sheets, other articles of vulcanized

rubber, plastic cases, cartons, boxes,

printed books, brochures and similar

printed matter, carboys, bottles, and

flasks, stoppers, caps, and lids,

aluminum foil, tin plates and sheets,

taps, cocks and valves, and medical

instruments and appliances.

FTZ procedures would exempt Merck

from Customs duty payments on the

foreign components used in export

activity. On its domestic sales, the

company would be able to elect the duty

rates that applies to finished products

(primarily duty-free for finished

pharmaceuticals and up to 14.6% for

intermediates) for the foreign materials

noted above (duty rates ranging from

duty-free to 14.5%). The application

indicates that the expanded use of FTZ

procedures will help improve Merck’s

international competitiveness.

The application has requested review

under § 400.32(b)(1) of the FTZ Board

regulations on the basis that the

proposed activity is the same, in terms

of products involved, to activity

recently approved by the Board and

similar in circumstances.

Public comment on the application is

invited from interested parties.

Submissions (original and three copies)

shall be addressed to the Board’s

Executive Secretary at the address

below. The closing period for their

receipt is January 2, 2001. Rebuttal

comments in response to material

submitted during the foregoing period

may be submitted during the subsequent

15-day period (to January 16, 2001).

Copies of the applications will be

available for public inspection at the

following locations:

U.S. Department of Commerce, Export

Assistance Center, 333 Fayetteville

St., Suite 1150, Raleigh, NC 27601

Office of the Executive Secretary,

Foreign-Trade Zones Board, Room

4008, U.S. Department of Commerce,

14th Street & Pennsylvania Avenue,

NW, Washington, DC 20230

Dated: November 17, 2000.

Dennis Puccinelli,

Executive Secretary.

[FR Doc. 00–30564 Filed 11–29–00; 8:45 am]

BILLING CODE 3510–DS–P

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Docket 60–2000]

Foreign-Trade Zone 35B—Philadelphia

Regional Port Authority; Expansion of

Facilities and Manufacturing

Authority—Subzone 35B; Merck & Co.,

Inc. Plant (Pharmaceuticals) West

Point, PA

An application has been submitted to

the Foreign-Trade Zones Board (the

Board) by the Philadelphia Regional

Port Authority, grantee of FTZ 35,

pursuant to § 400.32(b)(1) of the Board’s

regulations (15 CFR part 400),

requesting on behalf of Merck & Co., Inc.

(Merck), to add capacity and to expand

the scope of manufacturing authority

under zone procedures at Subzone 35B,

at the Merck pharmaceutical plant in

West Point, Pennsylvania. It was

formally filed on November 17, 2000.

Subzone 35B was approved by the

Board in 1994 at a single site (387 acres,

4,230,000 sq. ft., 83 bldgs.) located at

Sunneytown Pike and Broad Street, in

the town of West Point, Montgomery

County, Pennsylvania, some 15 miles

northwest of Philadelphia. The facility

(9,500 employees) is used to produce a

range of human health products. Merck

is now proposing to add 23 buildings

(totaling 2,087,280 sq. ft) and 18 acres.

The proposed subzone would then

include 106 bldgs., consisting of

6,317,280 sq. ft. (a 49% increase) on 405

acres.

The application also requests to

expand the scope of authority for

manufacturing activity conducted under

FTZ procedures at Subzone 35B to

include additional general categories of

inputs that have recently been approved

by the Board for other pharmaceutical

plants. They include chemically pure

sugars, empty capsules for

pharmaceutical use, protein

concentrates, natural magnesium

phosphates and carbonates, gypsum,

anhydrite and plasters, petroleum jelly,

paraffin and waxes, sulfuric acid, other

inorganic acids or compounds of

nonmetals, ammonia, zinc oxide,

titanium oxides, fluorides, chlorates,

sulfates, salts of oxometallic acids,

radioactive chemical elements,

compounds of rare earth metals, acyclic

hydrocarbons, derivatives of phenols or

peroxides, acetals and hemiacetals,

phosphoric esters and their salts, diazocompounds, glands for therapeutic uses,

wadding, gauze and bandages,

pharmaceutical glaze, hair preparations,

lubricating preparations, albumins,

prepared glues and adhesives, catalytic

preparations, diagnostic or laboratory

reagents, prepared binders, acrylic

polymers, self-adhesive plates and

sheets, other articles of vulcanized

rubber, plastic cases, cartons, boxes,

printed books, brochures and similar

printed matter, carboys, bottles, and

flasks, stoppers, caps, and lids,

aluminum foil, tin plates and sheets,

taps, cocks and valves, and medical

instruments and appliances.

FTZ procedures would exempt Merck

from Customs duty payments on the

foreign components used in export

activity. On its domestic sales, the

company would be able to elect the duty

rates that applies to finished products

(primarily duty-free for finished

pharmaceuticals and up to 14.6% for

intermediates) for the foreign materials

noted above (duty rates ranging from

duty-free to 14.5%). The application

indicates that the expanded use of FTZ

procedures will help improve Merck’s

international competitiveness.

The application has requested review

under § 400.32(b)(1) of the FTZ Board

regulations on the basis that the

proposed activity is the same, in terms

of products involved, to activity

recently approved by the Board and

similar in circumstances.

Public comment on the application is

invited from interested parties.

Submissions (original and three copies)

shall be addressed to the Board’s

Executive Secretary at the address

below. The closing period for their

receipt is January 2, 2001. Rebuttal

comments in response to material

submitted during the foregoing period

may be submitted during the subsequent

15-day period (to January 16, 2001).

Copies of the applications will be

available for public inspection at the

following locations:

Federal Register / Vol. 65, No. 231 / Thursday, November 30, 2000 / Notices 71299

U.S. Department of Commerce, Export

Assistance Center, 615 Chestnut St.,

Suite 1501, Philadelphia, PA 19106

Office of the Executive Secretary,

Foreign-Trade Zones Board, Room

4008, U.S. Department of Commerce,

14th Street & Pennsylvania Avenue,

NW, Washington, DC 20230

Dated: November 17, 2000.

Dennis Puccinelli,

Executive Secretary.

[FR Doc. 00–30563 Filed 11–29–00; 8:45 am]

BILLING CODE 3510–DS–P

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Docket 63–2000]

Foreign-Trade Zone 185C—Culpeper

County Chamber of Commerce

Expansion of Facilities and

Manufacturing Authority—Subzone

185C, Merck & Co., Inc. Plant

(Pharmaceuticals), Elkton, Virginia

An application has been submitted to

the Foreign-Trade Zones Board (the

Board) by the Culpeper County Chamber

of Commerce, grantee of FTZ 185,

pursuant to § 400.32(b)(1) of the Board’s

regulations (15 CFR Part 400),

requesting on behalf of Merck & Co., Inc.

(Merck), to add capacity and to expand

the scope of manufacturing authority

under zone procedures at Subzone

185C, at the Merck pharmaceutical plant

in Elkton, Virginia, was formally filed

on November 17, 2000.

Subzone 104A was approved by the

Board in 1994 at a single site (1,333

acres, 624,221 sq. ft., 82 bldgs.) located

on Route 340S, in Elkton (Rockingham

County), Virginia, some 20 miles east of

Harrisonburg. The facility (900

employees) is used to produce a range

of human health products. Merck is now

proposing to add 15 buildings and

additional capacity to existing buildings

(totaling 262,904 sq. ft). The proposed

subzone would then include 97 bldgs.

consisting of 887,125 sq. ft. (a 42%

increase) on 1,333 acres.

The application also requests to

expand the scope of authority for

manufacturing activity conducted under

FTZ procedures at Subzone185C to

include additional general categories of

inputs that have recently been approved

by the Board for other pharmaceutical

plants. They include chemically pure

sugars, empty capsules for

pharmaceutical use, protein

concentrates, natural magnesium

phosphates and carbonates, gypsum,

anhydrite and plasters, petroleum jelly,

paraffin and waxes, sulfuric acid, other

inorganic acids or compounds of

nonmetals, ammonia, zinc oxide,

titanium oxides, fluorides, chlorates,

sulfates, salts of oxometallic acids,

radioactive chemical elements,

compounds of rare earth metals, acyclic

hydrocarbons, derivatives of phenols or

peroxides, acetals and hemiacetals,

phosphoric esters and their salts, diazocompounds, glands for therapeutic uses,

wadding, gauze and bandages,

pharmaceutical glaze, hair preparations,

lubricating preparations, albumins,

prepared glues and adhesives, catalytic

preparations, diagnostic or laboratory

reagents, prepared binders, acrylic

polymers, self-adhesive plates and

sheets, other articles of vulcanized

rubber, plastic cases, cartons, boxes,

printed books, brochures and similar

printed matter, carboys, bottles, and

flasks, stoppers, caps, and lids,

aluminum foil, tin plates and sheets,

taps, cocks and valves, and medical

instruments and appliances.

FTZ procedures would exempt Merck

from Customs duty payments on the

foreign components used in export

activity. On its domestic sales, the

company would be able to elect the duty

rates that applies to finished products

(primarily duty-free for finished

pharmaceuticals and up to 14.6% for

intermediates) for the foreign materials

noted above (duty rates ranging from

duty-free to 14.5%). The application

indicates that the expanded use of FTZ

procedures will help improve Merck’s

international competitiveness.

The application has requested review

under § 400.32(b)(1) of the FTZ Board

regulations on the basis that the

proposed activity is the same, in terms

of products involved, to activity

recently approved by the Board and

similar in circumstances.

Public comment on the application is

invited from interested parties.

Submissions (original and three copies)

shall be addressed to the Board’s

Executive Secretary at the address

below. The closing period for their

receipt is January 2, 2001. Rebuttal

comments in response to material

submitted during the foregoing period

may be submitted during the subsequent

15-day period (to January 16, 2001).

Copies of the applications will be

available for public inspection at the

following locations:

Culpeper County Chamber of

Commerce, 133 West Davis Drive,

Culpeper, Virginia 22701

Office of the Executive Secretary,

Foreign-Trade Zones Board, Room

4008, U.S. Department of Commerce,

14th Street & Pennsylvania Avenue,

NW, Washington, DC 20230

Dated: November 17, 2000.

Dennis Puccinelli,

Executive Secretary.

[FR Doc. 00–30566 Filed 11–29–00; 8:45 am]

BILLING CODE 3510–DS–P

DEPARTMENT OF COMMERCE

International Trade Administration

Initiation of Antidumping and

Countervailing Duty Administrative

Reviews

AGENCY: Import Administration,

International Trade Administration,

Department of Commerce.

ACTION: Notice of Initiation of

Antidumping and Countervailing Duty

Administrative Reviews.

SUMMARY: The Department of Commerce

(the Department) has received requests

to conduct administrative reviews of

various antidumping and countervailing

duty orders and findings with October

anniversary dates. In accordance with

the Department’s regulations, we are

initiating those administrative reviews.

EFFECTIVE DATE: Novemeber 30, 2000.

FOR FURTHER INFORMATION CONTACT:

Holly A. Kuga, Office of AD/CVD

Enforcement, Import Administration,

International Trade Administration,

U.S. Department of Commerce, 14th

Street and Constitution Avenue, NW,

Washington, D.C. 20230, telephone:

(202) 482–4737.

SUPPLEMENTARY INFORMATION:

Background

The Department has received timely

requests, in accordance with 19 CFR

351.213(b)(2000), for administrative

reviews of various antidumping and

countervailing duty orders and findings

with October anniversary dates.

Initiation of Reviews

In accordance with section 19 CFR

351.221(c)(1)(i), we are initiating

administrative reviews of the following

antidumping and countervailing duty

orders and findings. We intend to issue

the final results of these reviews not

later than October 31, 2001.